EUVIMED · CrossrefZeitschrift
ACS Medicinal Chemistry Letters
ISSN 1948-5875 · American Chemical Society (ACS)
Neueste Artikel
Novel Piperidinyl-triazinyl-phenols for the Treatment of Inflammatory Diseases including Alzheimer’s and Parkinson’s Diseases
Correction to “Discovery of the U2AF1-UHM Inhibitor That Possesses Anti-Leukemia Activity In Vitro”
Novel Small Molecule Inhibitors of GSL-1 as Potential Agents for the Treatment of Metabolic Disorders
Discovery of a Novel Chemical Scaffold for Dual MDM2 and MDM4 Inhibition
An Integrated Approach Combining Receptor-Based Ensemble Screening and In Vivo Phenotypic Assessment Improves Drug-Induced Liver Injury Prediction
Development of YO-01027-Derived Signal Peptide Peptidase Inhibitors with Reduced γ-Secretase Inhibition
Discovery of Pyrazolopyrimidines as Potent and Orally Bioavailable MRGPRX2 Antagonists
Design, Synthesis, and Comparative Selection Analysis of a Chemically Diverse Peptide-Like DNA-Encoded Library
Accelerated Hit Identification and Optimization of a Novel Class of Cellularly Active QPCT/L Inhibitors
Development of Potent and Orally Bioavailable MALT1 Inhibitors for Sjögren’s Syndrome: Efficacy and Safety Assessment
Enhancing Natural Product Therapy with PROTACs: Targeted Degradation of TLR4 Confers Potent Endothelial Protection
Discovery and In Vitro Characterization of Macrocyclic 2-(Heteroaryl)Pyrimidine Inhibitors Targeting Wild-Type KRAS and G12D/G12V Mutants
Discovery of N -Acyl Pyrimidine-Biphenyl Small-Molecule PD-L1 Inhibitors that Restore T Cell Function and Suppress Tumor Growth in Breast Cancer
Pyridazino-Indoles as Phenol Bioisosteres for Potent Inhibition of NLRP3
Design, Synthesis, and Biological Evaluations of Constrained Ugi Adducts as Anti-JEV Agents
Preliminary Studies of Sustained Systemic TLR4 Inhibition and Reduced Sensorineural Hearing Loss by Soluble TAK-242 Prodrug
Can PBPK Modeling Improve Compound Optimization and Medicinal Chemistry Decision-Making in Complex Chemical Space?
Synthesis and Evaluation of Mevalonate Diphosphate Analogs as Butyrophilin 3A3 Ligands
A Nontoxin Aminopyrimidine Probe for Near State-Independent NaV1.7 Inhibition
Investigation of Chiral Imidazoquinoline Based Heterocyclic Small Molecules on TLR7/8 Modulatory Activity
A High-Throughput Screening Platform for the Discovery of Noncovalent Inhibitors of the ISG15–UBA7 Interaction
Discovery of G2019S Mutant Selective LRRK2 Inhibitors Based on an Indazole Octahydrocyclopenta[ c ]pyrrole-Based Hybrid Chemotype
Novel Aminocyclohexenyl-6,6-bicyclic Compounds as 5-HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches
Who Knows Medicinal Chemistry? Expertise, Attrition, and the Dissolving Boundaries of a Craft
Structural Insights into Brain-Penetrant EGFR Tyrosine Kinase Inhibitors with Enhanced Potency
Novel Substituted Pyrazoles as SARM1 Inhibitors
Novel Substituted Spiro-Carbamates as MAGL Fluorescent, Raman, and PET Probes
Novel Carboxamide-Based PKMYT1 Inhibitors for Replication Stress-Associated Cancers
Vasopressin Receptor 2 Modulators for the Treatment of Related Disorders
Novel Compounds as TREM2 Agonists for Treating Parkinson’s Disease, Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Nasu-Hakola Disease, and Stroke
EUVIMED